This compound is primarily utilized in the development of pharmaceutical agents, particularly as a key intermediate in the synthesis of biologically active molecules. Its structure, featuring both trifluoromethyl and cyclohexylamino groups, makes it suitable for targeting specific enzymes or receptors in drug discovery. It is often employed in the creation of inhibitors for enzymes involved in disease pathways, such as those related to cancer or inflammatory conditions. Additionally, its unique chemical properties allow it to be used in medicinal chemistry research to optimize drug potency and selectivity. The compound’s trifluoromethyl groups enhance its metabolic stability, making it a valuable component in the design of long-acting therapeutic agents.